...
首页> 外文期刊>Molecular medicine reports >High-dose fasudil preconditioning and postconditioning attenuate myocardial ischemia-reperfusion injury in hypercholesterolemic rats
【24h】

High-dose fasudil preconditioning and postconditioning attenuate myocardial ischemia-reperfusion injury in hypercholesterolemic rats

机译:大剂量法舒地尔预处理和后处理可减轻高胆固醇血症大鼠的心肌缺血-再灌注损伤

获取原文
获取原文并翻译 | 示例

摘要

Fasudil may induce preconditioning and postconditioning against myocardial ischemia-reperfusion injury in normal rats, however, their effectivenesses in hypercholesterolemia remains to be determined. The study aimed to investigate whether fasudil induces preconditioning and postconditioning in hypercholesterolemic rats and to determine the roles of the phosphoinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) pathway and mitochondrial KATP (m-KATP) channels in this process. Isolated rat hearts underwent 30 min global ischemia and 120 min reperfusion. Low- (1 mg/kg) or high-dose (10 mg/kg) fasudil was administered 15 min prior to ischemia and at the initial onset of reperfusion. 5-Hydroxydecanoic acid (5HD), an m-KATP channel blocker, at 10 mg/kg was administered 5 min prior to reperfusion. Myocardial infarct size was estimated by 2,3,5-triphenyltetrazolium chloride (TTC) staining and lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB) were analyzed from coronary effluents. Phosphorylation of Akt and eNOS was measured by immunoblotting. High-dose fasudil-induced preconditioning and postconditioning significantly reduced infarct size and the release of LDH and CK-MB and increased the phosphorylation of Akt and eNOS compared with the control group, whereas low-dose fasudil did not exert these beneficial effects. In addition, the cardioprotection of high-dose fasudil-induced preconditioning and postconditioning are blocked by 5HD. Low-dose fasudil-induced preconditioning and postconditioning are abrogated by hypercholesterolemia, while high-dose fasudil restores the cardioprotection, which is involved in upregulation of the PI3K/Akt/eNOS pathway and inducing the opening of the m-KATP channel.
机译:法舒地尔可能在正常大鼠中诱导针对心肌缺血-再灌注损伤的预处理和后处理,但是,其在高胆固醇血症中的有效性尚待确定。该研究旨在调查法舒地尔是否在高胆固醇血症大鼠中诱导预处理和后处理,并确定磷酸肌醇3-激酶(PI3K)/ Akt /内皮型一氧化氮合酶(eNOS)途径和线粒体KATP(m-KATP)通道的作用。处理。离体大鼠心脏经历了30分钟的整体缺血和120分钟的再灌注。在缺血前和初次再灌注开始前15分钟,给予低剂量(1 mg / kg)或高剂量(10 mg / kg)的法舒地尔。在再灌注前5分钟,以10 mg / kg的剂量使用5-羟癸酸(5HD),一种m-KATP通道阻滞剂。通过2,3,5-三苯基四唑氯化物(TTC)染色估算心肌梗塞面积,并从冠状流出物中分析乳酸脱氢酶(LDH)和肌酸激酶-MB(CK-MB)。通过免疫印迹测量Akt和eNOS的磷酸化。与对照组相比,大剂量法舒地尔诱导的预处理和后适应显着减少了梗塞面积以及LDH和CK-MB的释放,并增加了Akt和eNOS的磷酸化,而低剂量法舒地尔没有发挥这些有益作用。另外,大剂量法舒地尔诱导的预处理和后处理的心脏保护作用被5HD阻断。高胆固醇血症废除了低剂量法舒地尔引起的预处理和后适应,而高剂量法舒地尔恢复了心脏保护作用,这参与了PI3K / Akt / eNOS途径的上调并诱导了m-KATP通道的开放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号